F2G Ltd. will share Phase 3 OASIS trial findings for its investigational antifungal at the conference this October.
Live Poll
Would you participate in a clinical trial for a life-threatening infection with limited treatment options?
October 5, 2026
RSV Season Has Arrived Across United StatesFederal health officials have confirmed the start of the annual respiratory syncytial virus season.
October 5, 2026
Strep Bacteria Resistance Has Increased SignificantlyA pediatric specialist noted that 30% of group A strep cases now show resistance to common antibiotics.
October 5, 2026
EPA Filed Brief Supporting Air Quality ChallengeThe agency responded to a legal challenge from 25 states regarding particulate matter standards.
October 5, 2026
Rheumatologists Reviewed Scleroderma Lung Disease GuidelinesExperts examined updated treatment protocols for managing interstitial lung disease in systemic sclerosis patients.
October 4, 2026
AstraZeneca COPD Drug Trial Showed Positive ResultsThe OBERON and TITANIA clinical trials demonstrated that tozorakimab reduced COPD exacerbation rates in patients.
October 2, 2026
COPD Foundation Observed World Oxygen DayThe foundation highlighted oxygen access challenges as advocacy groups push for federal reform.
October 2, 2026
FDA Classified BMC Medical APAP Device RecallThe FDA issued a Class I recall for 20,160 Luna G3 APAP units due to a critical firmware defect causing potential shutdowns.
October 2, 2026
Lionel Richie Will Return to American Idol in 2027The veteran judge confirmed his involvement for the show's upcoming 25th anniversary season.
October 2, 2026
Dermatology Experts Explored New Oral Treatment OptionsResearchers have focused on oral small molecules to expand treatment choices for patients with atopic dermatitis.
October 1, 2026
Trump Hand Discoloration Linked to Daily Aspirin UseThe White House confirmed that the President uses makeup to manage bruising on his hand while maintaining an aspirin regimen.
